Document is current

Any future updates will be listed below

Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome

Crossref DOI link: https://doi.org/10.1186/s13613-014-0022-z

Published Online: 2014-07-03

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark